Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Procabazi Injection
Manufacturer/Marketed By : Glenmark Pharmaceuticals Ltd
$137.13 $97.94
Sidmex Inovia offers bulk export supply of Procabazi Injection (Cabazitaxel 60 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and...
Cabazitaxel 60 mg
Active Pharmaceutical Ingredient
Procabazi Injection
$137.13
$97.94
Sidmex Inovia offers bulk export supply of Procabazi Injection (Cabazitaxel 60 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Procabazi injection, containing 60 mg of cabazitaxel, is an innovative anti-cancer medication specifically designed to combat prostate cancer that has proven resistant to traditional hormonal therapies and has metastasized beyond its original site. Often administered in conjunction with the steroid prednisone, this treatment is particularly beneficial for men whose prostate cancer has not responded effectively to prior treatments such as docetaxel. By targeting and inhibiting cancer cell growth, Procabazi helps to slow the progression of the disease and improve patient outcomes. It’s important to note that the safety and efficacy of this injection in pediatric patients have not been established, so it is not recommended for use in children. Patients should discuss potential side effects and any pre-existing health conditions with their healthcare provider before starting this treatment. As with any cancer therapy, careful monitoring during treatment is essential to manage any adverse reactions effectively. Procabazi represents a vital option in the ongoing fight against advanced prostate cancer, offering hope for those affected by this challenging condition.
Active Pharmaceutical Ingredient
Uses
• Procabazi injection is primarily indicated for the treatment of prostate cancer. This medication helps manage symptoms associated with the disease, such as frequent urination and difficulty in urination. Patients may also experience discomfort in the lower back, hips, or pelvis, which Procabazi injection aims to alleviate. By addressing these symptoms, the injection improves the overall quality of life for individuals undergoing treatment.
• In cases where prostate cancer leads to complications, Procabazi injection can be an essential part of the therapeutic regimen. It helps reduce the severity of symptoms like blood in the urine or semen, which can be distressing for patients. By effectively managing these complications, Procabazi injection supports patients in navigating their treatment journey. This allows healthcare providers to focus on comprehensive care tailored to individual needs.
• Procabazi injection is often utilized in conjunction with other treatment modalities for prostate cancer. Its role in symptom management complements surgical or radiological interventions, enhancing overall treatment outcomes. Patients receiving Procabazi injection may find it beneficial in reducing the side effects of more aggressive therapies. This multifaceted approach can lead to improved patient satisfaction and adherence to treatment plans.
• Healthcare professionals may recommend Procabazi injection based on individual patient assessments and treatment goals. The injection is designed to provide targeted relief from prostate cancer-related symptoms, thus enabling patients to maintain daily activities. By incorporating Procabazi injection into the treatment plan, clinicians can offer a more holistic approach to cancer care. This integration helps ensure that patients receive optimal support throughout their therapy.
Benefits
Prostate cancer is a type of cancer that develops in the prostate gland, which is a small walnut-shaped gland in the male reproductive system. Prostate cancer usually grows slowly and may not cause any symptoms at first. However, as it grows, it can cause symptoms such as frequent urination, difficulty urinating, blood in the urine or semen, and pain in the lower back, hips, or pelvis. Procabazi 60 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells in men. This also relieves difficulty in passing urine and makes it easier for you to urinate.
Side Effects
Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.
Most Common Side Effects
• Vomiting
• Constipation
• Taste changes
• Nausea
• Weakness
Common Side Effects
• Shortness of breath



